The second major research study of the project

 

The SData study takes place in the United Kingdom, Greece and Germany. It is a more controlled research study that involves medical examination and optional, additional-to-GData data collection via an upgraded version of the iPrognosis app and a smartwatch. The target number of study participants, Parkinson’s disease patients and healthy controls, is 80 across the three countries.

Read the participant information sheet in your language to learn more about the study, by clicking on the corresponding country below.


UK
UK
GR
Greece
DE
Germany

Please note that participating in this study requires visiting one of the clinical sites listed below. If your are interested in participating in the SData study or want to learn more, please first contact your nearest clinical site via e-mail or telephone. Participation depends on whether the target number of participants (80) has been reached and is subject to inclusion/ exclusion criteria.


United Kingdom

Neurology Department, King’s College Hospital
London
Telephone: 0203 299 8336
E-mail: kch-tr.PDresearch@nhs.net

Germany

Klinik und Poliklinik für Neurologie
Universitätsklinikum Carl Gustav Carus der Technischen Universität

Dresden
Telephone: 0351 458 3565
E-mail: iprognosis@ukdd.de

Greece

Third Neurological Clinic, Aristotle University of Thessaloniki
Thessaloniki
Telephone: 2313 307 330
E-mail: info@i-prognosis.eu